Incorporation of a GnRH agonist, leuprolide acetate, into regimens with exogenous gonadotropins to produce ovarian stimulation and ovulation in the nonpregnant squirrel monkey
Tj. Kuehl et al., Incorporation of a GnRH agonist, leuprolide acetate, into regimens with exogenous gonadotropins to produce ovarian stimulation and ovulation in the nonpregnant squirrel monkey, AM J PRIMAT, 49(2), 1999, pp. 153-164
This study was designed to measure the effects of variations in the length
of pretreatment with a GnRH agonist, leuprolide acetate (LA), on subsequent
follicular development and ovulation. The hypothesis was that the duration
of LA suppression of pituitary function does not adversely affect ovarian
response to standardized ovulation induction protocols in squirrel monkeys,
The first phase determined the dose and duration of LA needed to achieve a
hypogonadal state. One of two groups received daily subcutaneous injection
s of 50 mu g of LA, The other received a single injection of 175 mu g of a
depot suspension of LA, Sera were assayed for estradiol (E2) and progestero
ne (P), E2 and P levels increased 2- to 5-fold with peak levels on days 4 a
nd 7, respectively. Suppression of steroid levels took 10 to 15 days in the
LA-treated group. Depot-LA did not effectively suppress steroid production
. After suppression, females receiving daily LA received five daily injecti
ons of hMG to stimulate follicular development. E2 and P increased in these
animals. These results suggest that cycling squirrel monkeys have P-secret
ing capacity throughout the cycle. This may explain how the squirrel monkey
is able to accommodate both a short (4-5 day) luteal phase of their 9 day
cycle and implantation from 5 to 7 days after ovulation.
A second study compared exogenous follicle stimulating hormone (FSH) to end
ogenous gonadotropins released as a response to LA in ovulation induction,
Steroid production and hCG-induced ovulation were assessed. LA treatment wa
s compared to a standard ovulation induction protocol by using a randomized
cross-over measures design.
There were no differences in E2 and P levels in response to dosages of eith
er LA or hMG. The ovulatory response following LA treatment was not signifi
cantly greater than that using FSH. The number of animals with unovulated,
large follicles was greater on the FSH protocol (12/18) compared to the LA
protocol (3/18). Thus, a single injection of a depot preparation of LA is s
ufficient to stimulate follicular development and ovulation when followed b
y an hCG injection. Based on this observation and the data on unovulated la
rge follicles, it is suggested that the ovary responds more readily to endo
genous gonadotropins released by LA than to exogenous FSH. (C) 1999 Wiley-L
iss, Inc.